Skip to main content
. 2022 Jun 27;22:294. doi: 10.1186/s12872-022-02722-6

Table 2.

Laboratorial data from non-drug naive and drug-naive T2DM patients at the beginning of the study

Group 1
(non-drug naive)
Group 2
(drug-naive)
p
N = 978 N = 221
Glycemia (mg/dL) 174 ± 56 187 ± 65  < 0.05
Glycated hemoglobin (%) 8.6 ± 1.6 8.9 ± 2.1  < 0.001
Glomerular filtration ratio (mL/min) 84 ± 24 106 ± 34  < 0.001
Albuminuria (mg/g) 168 ± 170 38 ± 101  < 0.001
Total cholesterol (mg/dL) 198 ± 48 212 ± 55  < 0.001
Triglycerides (mg/dL) 207 ± 115 222 ± 154 0.8
HDL-C(mg/dL) 43 ± 11 41 ± 9  < 0.05
LDL-C (mg/dL) 115 ± 41 130 ± 42  < 0.001

T2DM Type 2 diabetes mellitus, NS Not significant, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol. Group 1 Individuals with T2DM undergoing drug treatment, Group 2 Newly diagnosed drug-naive (< 3 months) patients with T2DM. Statistical significance was set at p < 0.05